Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML

NCT01274195 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Busulfan

Sponsor

Seoul National University Hospital